122 related articles for article (PubMed ID: 32039931)
1. Suicide risk among prostate cancer patients before and after the implementation of prostate-specific antigen-based prostate screening in Lithuania in 2006.
Patasius A; Kaceniene A; Ulys A; Stukas R; Smailyte G
Eur J Cancer Prev; 2021 Jan; 30(1):103-107. PubMed ID: 32039931
[TBL] [Abstract][Full Text] [Related]
2. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.
Bill-Axelson A; Garmo H; Lambe M; Bratt O; Adolfsson J; Nyberg U; Steineck G; Stattin P
Eur Urol; 2010 Mar; 57(3):390-5. PubMed ID: 19914773
[TBL] [Abstract][Full Text] [Related]
3. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
Fang F; Keating NL; Mucci LA; Adami HO; Stampfer MJ; Valdimarsdóttir U; Fall K
J Natl Cancer Inst; 2010 Mar; 102(5):307-14. PubMed ID: 20124521
[TBL] [Abstract][Full Text] [Related]
4. Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme.
Smailyte G; Aleknaviciene B
Public Health; 2012 Dec; 126(12):1075-7. PubMed ID: 22381571
[TBL] [Abstract][Full Text] [Related]
5. Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programme.
Gondos A; Krilaviciute A; Smailyte G; Ulys A; Brenner H
Eur J Cancer; 2015 Aug; 51(12):1630-7. PubMed ID: 26044924
[TBL] [Abstract][Full Text] [Related]
6. Increasing suicide risk among cancer patients in Lithuania from 1993 to 2012: a cancer registry-based study.
Kaceniene A; Krilaviciute A; Kazlauskiene J; Bulotiene G; Smailyte G
Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S197-S203. PubMed ID: 28914692
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data.
Smith DP; Calopedos R; Bang A; Yu XQ; Egger S; Chambers S; O'Connell DL
PLoS One; 2018; 13(6):e0198679. PubMed ID: 29897979
[TBL] [Abstract][Full Text] [Related]
8. Suicide risk among colorectal cancer patients in Lithuania.
Dulskas A; Patasius A; Kaceniene A; Urbonas V; Smailyte G
Int J Colorectal Dis; 2019 Mar; 34(3):555-558. PubMed ID: 30617411
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.
Buzzoni C; Auvinen A; Roobol MJ; Carlsson S; Moss SM; Puliti D; de Koning HJ; Bangma CH; Denis LJ; Kwiatkowski M; Lujan M; Nelen V; Paez A; Randazzo M; Rebillard X; Tammela TL; Villers A; Hugosson J; Schröder FH; Zappa M
Eur Urol; 2015 Nov; 68(5):885-90. PubMed ID: 25791513
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
[TBL] [Abstract][Full Text] [Related]
11. US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses.
Gejerman G; Ciccone P; Goldstein M; Lanteri V; Schlecker B; Sanzone J; Esposito M; Rome S; Ciccone M; Margolis E; Simon R; Guo Y; Pentakota SR; Sadeghi-Nejad H
Investig Clin Urol; 2017 Nov; 58(6):423-428. PubMed ID: 29124241
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
[TBL] [Abstract][Full Text] [Related]
13. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
Hattangadi JA; Chen MH; D'Amico AV
BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
[TBL] [Abstract][Full Text] [Related]
14. Risk of suicide in men with low-risk prostate cancer.
Carlsson S; Sandin F; Fall K; Lambe M; Adolfsson J; Stattin P; Bill-Axelson A
Eur J Cancer; 2013 May; 49(7):1588-99. PubMed ID: 23337463
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.
Neupane S; Steyerberg E; Raitanen J; Talala K; Pylväläinen J; Taari K; Tammela TL; Auvinen A
Int J Urol; 2018 Mar; 25(3):270-276. PubMed ID: 29224236
[TBL] [Abstract][Full Text] [Related]
17. All-Cause Mortality Risk in National Prostate Cancer Cohort: An Impact of Population-Based Prostate Cancer Screening.
Patasius A; Smailyte G
J Clin Med; 2021 Jun; 10(11):. PubMed ID: 34206127
[TBL] [Abstract][Full Text] [Related]
18. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
[TBL] [Abstract][Full Text] [Related]
19. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.
Carlsson S; Assel M; Sjoberg D; Ulmert D; Hugosson J; Lilja H; Vickers A
BMJ; 2014 Mar; 348():g2296. PubMed ID: 24682399
[TBL] [Abstract][Full Text] [Related]
20. Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing.
Lavallée LT; Binette A; Witiuk K; Cnossen S; Mallick R; Fergusson DA; Momoli F; Morash C; Cagiannos I; Breau RH
Mayo Clin Proc; 2016 Jan; 91(1):17-22. PubMed ID: 26688045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
